A new strategy strengthens the bond between the T cell and a target tumor cell, improving the cytotoxic function of the T cell.
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
Key takeawaysResearchers and scientists have engineered a new class of supercharged T cells that are stronger, longer-lasting ...
Crossbow announced it raised $77 million in a Series B financing that will advance the development of TCR-mimetic antibody ...
Morning Overview on MSN
Researchers map real-time signals that trigger T cell activation
A cluster of recent studies has sharpened the scientific picture of how T cells switch on, tracking the molecular signals ...
Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.
The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, have engineered a new ...
T cell activation—the process by which these key immune defenders recognize threats and mobilize against them—depends on exquisitely timed molecular signals. Now researchers have captured one of the ...
Enara Bio, a pioneer in Dark Antigen(R) discovery and bispecific T cell engager innovation, today announced new data to be presented at the American Association for Cancer Research (AACR) Annual ...
Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results